CD163 and peripheral arterial disease: After adjusting for HDL cholesterol, triglycerides, smoking, CAD, PAD, CCB, β-blockers, and T2D treatment, the increase in sCD163 with the thickness of the ILT tended to remain significant (β = 1.313, p = 0.064).